Tracking Renal Tumors After Cryoablation Evaluation (TRACE)
Galil Medical has launched TRACE, a multi-center registry (data collection study) of patients who have undergone renal cryoablation per their physician's standard of care. Patients 18 years of age or older who have been determined to be an appropriate candidate for cryoablation will be offered enrollment into the registry.
- Approximately 250 patients are initially expected to enroll among 10 registry sites and will be treated and followed per their physician’s standard of care
- The registry will collect data on patients for five years from the date of their cryoablation procedure
- Data will assess the outcomes associated with the various procedural techniques (laparoscopic, open and percutaneous)
- Data obtained will be used in conjunction with data from randomized studies to evaluate the use, safety, and effectiveness of cryotherapy for renal lesions
- The registry will be used to evaluate short- and long-term surveillance of patients undergoing renal lesion cryoablation (e.g. disease recurrence or progression, disease specific survival, and overall survival)
- The registry may be used as a continuous quality improvement tool on behalf of practicing physicians and will contribute to the development and refinement of standards of care for renal lesion cryoablation
Additional information may be found at
TRACE Clinical Trial Information on CT.GOV
If you would like more information please contact:
Galil Medical
Joy Benson
651-287-5112 or joy.benson@galilmedical.com
Participating Registry Sites actively recruiting patients:
United States, California
University of California Irvine
Department of Urology
333 City Blvd West, Suite 2100
Orange, CA 92868
Principal Investigator: Jaime Landman, MD
United States, Colorado
Kaiser Permanente
Department Of Vascular Therapy
2045 Franklin Street, Third Floor
Denver CO 80205
Principal Investigator: Amit Sudan, MD
United States, Kentucky
University of Kentucky
Division of Urology
800 Rose St, MS283
Lexington, KY 40536-0298
Principal Investigator: Stephen Strup, MD
United States, Nebraska
University of Nebraska
Section of Urology
982360 Nebraska Medical Center
Omaha, NE 68198
Principal Investigator: Chad LaGrange, MD
United States, New York
Columbia University
Department of Urology
161 Fort Washington Ave
11th Floor
New York, NY 10032
Principal Investigator: Ketan Badani, MD
United States, South Carolina
Medical University of South Carolina
Department of Urology
135 Rutledge Avenue, Rm 522
PO Box 250557
Charleston, SC 29425
Principal Investigator: Stephen Savage, MD
United States, Tennessee
Vanderbilt University
Department of Urologic Surgery,
A-1302, MCN, 1161 21st Avenue
South Nashville, TN 37232
Principal Investigators: Stanley Duke Herrell, MD,
Peter Clark, MD |
